GlassScriptPhysician profile
Kent Kirby
NPI 1013980697
$4,502.15
in general payments reported to CMS, 2019-2025
31 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $287 · 2021: $649 · 2022: $951 · 2023: $543 · 2024: $360 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126 · Travel and Lodging: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.80 |
| Travel and Lodging | $444.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $540.89 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic, INC. | $469.40 | 2021-2025 | Altaviva |
| Pfizer INC. | $377.25 | 2019-2025 | |
| Myovant Sciences INC. | $310.81 | 2021-2022 | |
| Abbvie INC. | $248.15 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $246.59 | 2019-2023 | Xiaflex, Aveed |
| Teleflex LLC | $233.06 | 2023-2025 | Urolift |
| Janssen Biotech, INC. | $231.70 | 2019-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $207.01 | 2021-2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $185.00 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $169.40 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $167.27 | 2019-2025 | Speedicath, Titan |
| Urovant Sciences INC | $161.12 | 2021-2022 | |
| Olympus America INC. | $123.61 | 2022-2023 | Itind System |
| Axonics, INC. | $112.35 | 2022-2024 | Bulkamid, Axonics |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $103.58 | 2019-2022 | |
| Dentsply Ih Ab | $84.94 | 2021-2025 | Lofric, Lofric |
| Astrazeneca Pharmaceuticals LP | $75.48 | 2020-2021 | |
| Amgen INC. | $57.31 | 2022-2023 | Xgeva |
| Janssen Scientific Affairs, LLC | $51.18 | 2019-2020 | |
| Urogen Pharma, INC. | $49.83 | 2024 | |
| Medtronic USA, INC. | $49.19 | 2019 | |
| Allergan, INC. | $42.30 | 2019-2021 | |
| Endo USA, INC. | $38.88 | 2024 | Xiaflex |
| Blue Earth Diagnostics | $34.61 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $33.44 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Procept Biorobotics Corporation | $29.65 | 2023 | Aquabeam Robotic System |
| Dentsply Ih INC. | $26.79 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $15.02 | 2021 | |
| Cook Medical LLC | $14.50 | 2022 | |
| Boston Scientific Corporation | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.